Literature DB >> 20447537

Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study.

Andreas Kalogeropoulos1, Vasiliki Georgiopoulou, Bruce M Psaty, Nicolas Rodondi, Andrew L Smith, David G Harrison, Yongmei Liu, Udo Hoffmann, Douglas C Bauer, Anne B Newman, Stephen B Kritchevsky, Tamara B Harris, Javed Butler.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate the association between inflammation and heart failure (HF) risk in older adults.
BACKGROUND: Inflammation is associated with HF risk factors and also directly affects myocardial function.
METHODS: The association of baseline serum concentrations of interleukin (IL)-6, tumor necrosis factor-alpha, and C-reactive protein (CRP) with incident HF was assessed with Cox models among 2,610 older persons without prevalent HF enrolled in the Health ABC (Health, Aging, and Body Composition) study (age 73.6 +/- 2.9 years; 48.3% men; 59.6% white).
RESULTS: During follow-up (median 9.4 years), HF developed in 311 (11.9%) participants. In models controlling for clinical characteristics, ankle-arm index, and incident coronary heart disease, doubling of IL-6, tumor necrosis factor-alpha, and CRP concentrations was associated with 29% (95% confidence interval: 13% to 47%; p < 0.001), 46% (95% confidence interval: 17% to 84%; p = 0.001), and 9% (95% confidence interval: -1% to 24%; p = 0.087) increase in HF risk, respectively. In models including all 3 markers, IL-6, and tumor necrosis factor-alpha, but not CRP, remained significant. These associations were similar across sex and race and persisted in models accounting for death as a competing event. Post-HF ejection fraction was available in 239 (76.8%) cases; inflammatory markers had stronger association with HF with preserved ejection fraction. Repeat IL-6 and CRP determinations at 1-year follow-up did not provide incremental information. Addition of IL-6 to the clinical Health ABC HF model improved model discrimination (C index from 0.717 to 0.734; p = 0.001) and fit (decreased Bayes information criterion by 17.8; p < 0.001).
CONCLUSIONS: Inflammatory markers are associated with HF risk among older adults and may improve HF risk stratification. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447537      PMCID: PMC3267799          DOI: 10.1016/j.jacc.2009.12.045

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  53 in total

Review 1.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

Authors:  J S Yudkin; M Kumari; S E Humphries; V Mohamed-Ali
Journal:  Atherosclerosis       Date:  2000-02       Impact factor: 5.162

2.  Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study.

Authors:  Peter A McCullough; Edward F Philbin; John A Spertus; Scott Kaatz; Keisha R Sandberg; W Douglas Weaver
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

3.  Long-term trends in the incidence of and survival with heart failure.

Authors:  Daniel Levy; Satish Kenchaiah; Martin G Larson; Emelia J Benjamin; Michelle J Kupka; Kalon K L Ho; Joanne M Murabito; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

4.  Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction.

Authors:  R J Raymond; G J Dehmer; T C Theoharides; E N Deliargyris
Journal:  Am Heart J       Date:  2001-03       Impact factor: 4.749

5.  Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.

Authors:  J S Gottdiener; A M Arnold; G P Aurigemma; J F Polak; R P Tracy; D W Kitzman; J M Gardin; J E Rutledge; R C Boineau
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

6.  Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study.

Authors:  Irene M van der Meer; Moniek P M de Maat; Michiel L Bots; Monique M B Breteler; John Meijer; Amanda J Kiliaan; Albert Hofman; Jacqueline C M Witteman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

7.  Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.

Authors:  Subodh Verma; Shu-Hong Li; Mitesh V Badiwala; Richard D Weisel; Paul W M Fedak; Ren-Ke Li; Bikramjit Dhillon; Donald A G Mickle
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

8.  Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction.

Authors:  Shunji Hayashidani; Hiroyuki Tsutsui; Tetsuya Shiomi; Nobuhiro Suematsu; Shintaro Kinugawa; Tomomi Ide; Jing Wen; Akira Takeshita
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

9.  TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling.

Authors:  William S Bradham; Gordon Moe; Katherine A Wendt; Amelia A Scott; Andrea Konig; Marina Romanova; George Naik; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-04       Impact factor: 4.733

10.  Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy.

Authors:  S Van Linthout; A Riad; N Dhayat; F Spillmann; J Du; S Dhayat; D Westermann; D Hilfiker-Kleiner; M Noutsias; U Laufs; H-P Schultheiss; C Tschöpe
Journal:  Diabetologia       Date:  2007-06-23       Impact factor: 10.122

View more
  156 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  The demographic and medical correlates of plasma aβ40 and aβ42.

Authors:  Andrea L Metti; Jane A Cauley; Hilsa N Ayonayon; Tamara B Harris; Caterina Rosano; Jeff D Williamson; Kristine Yaffe
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jul-Sep       Impact factor: 2.703

3.  Advances in Cardiovascular Health in Women over the Past Decade: Guideline Recommendations for Practice.

Authors:  Pejman Raeisi-Giglou; Annabelle Santos Volgman; Hena Patel; Susan Campbell; Amparo Villablanca; Eileen Hsich
Journal:  J Womens Health (Larchmt)       Date:  2017-07-17       Impact factor: 2.681

4.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

5.  Cytokines profile of reverse cardiac remodeling following transcatheter aortic valve replacement.

Authors:  Juyong Brian Kim; Yukari Kobayashi; Tatiana Kuznetsova; Kegan J Moneghetti; Daniel A Brenner; Ryan O'Malley; Catherine Dao; Joseph C Wu; Michael Fischbein; D Craig Miller; Alan C Yeung; David Liang; Francois Haddad; William F Fearon
Journal:  Int J Cardiol       Date:  2018-11-01       Impact factor: 4.164

6.  Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study.

Authors:  Todd H Driver; Ronit Katz; Joachim H Ix; Jared W Magnani; Carmen A Peralta; Chirag R Parikh; Linda Fried; Anne B Newman; Stephen B Kritchevsky; Mark J Sarnak; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2014-03-18       Impact factor: 8.860

Review 7.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Ken Kaila; Mark J Haykowsky; Richard B Thompson; D Ian Paterson
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

8.  Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study.

Authors:  Catherine N Marti; Hassan Khan; Douglas L Mann; Vasiliki V Georgiopoulou; Kirsten Bibbins-Domingo; Tamara Harris; Annemarie Koster; Anne Newman; Stephen B Kritchevsky; Andreas P Kalogeropoulos; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-12-09       Impact factor: 8.790

9.  Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults.

Authors:  Konstantinos N Aronis; Na Wang; Caroline L Phillips; Emelia J Benjamin; Gregory M Marcus; Anne B Newman; Nicolas Rodondi; Suzanne Satterfield; Tamara B Harris; Jared W Magnani
Journal:  Am Heart J       Date:  2015-06-14       Impact factor: 4.749

10.  Prognostic value of increased carbohydrate antigen in patients with heart failure.

Authors:  Ana B Méndez; Jordi Ordoñez-Llanos; Andreu Ferrero; Mariana Noguero; Teresa Mir; Josefina Mora; Antoni Bayes-Genis; Sònia Mirabet; Juan Cinca; Eulàlia Roig
Journal:  World J Cardiol       Date:  2014-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.